Disclosed positions
| ISHARES TR | ACWI | MSCI ACWI ETF | $197,728,359 | 1,259,657 | SH | None |
| KARMAN HLDGS INC | KRMN | COM | $77,977,736 | 1,562,054 | SH | None |
| REVOLUTION MEDICINES INC | RVMD | COM | $64,441,362 | 344,091 | SH | None |
| TANGO THERAPEUTICS INC | TNGX | COM | $11,072,042 | 354,192 | SH | None |
| MAZE THERAPEUTICS INC | MAZE | COM | $7,161,421 | 239,994 | SH | None |
| MEDLINE INC | MDLN | COM | $2,698,209 | 68,413 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 0 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.